Mario Gaudino1, Irbaz Hameed2, Antonino Di Franco3, Ajita Naik3, Michelle Demetres4, Giuseppe Biondi-Zoccai5, Sripal Bangalore6. 1. Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY. Electronic address: mfg9004@med.cornell.edu. 2. Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY; Section of Cardiac Surgery, Yale University School of Medicine, New Haven, Conn. 3. Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY. 4. Samuel J. Wood Library and C.V. Starr Biomedical Information Center, Weill Cornell Medicine, New York, NY. 5. Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy; Mediterranea Cardiocentro, Napoli, Italy. 6. New York University Grossman School of Medicine, New York, New York, NY.
Abstract
OBJECTIVES: The evidence supporting the use of the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) score for risk stratification is controversial. We performed a systematic review and meta-analysis of all the randomized controlled trials comparing percutaneous coronary intervention versus coronary artery bypass grafting that reported their outcomes stratified by SYNTAX score, focusing on between-strata comparisons. METHODS: A systematic review of MEDLINE, EMBASE, Cochrane Library databases was performed. Incidence rate ratios were pooled with a random effect model. Between-group statistical heterogeneity according to accepted SYNTAX score tertiles was computed in the main analysis. Ratios of incidence rate ratios were computed to appraise between-strata effect, as sensitivity analysis. Primary and secondary outcomes were major adverse cardiac and cerebrovascular events and all-cause mortality, respectively. Separate sub-analyses were performed for left main and multivessel disease. RESULTS: From 425 citations, 6 trials were eventually included (8269 patients [4134 percutaneous coronary interventions, 4135 coronary artery bypass graftings]; mean follow-up: 6.2 years [range: 3.8-10]). Overall, percutaneous coronary intervention was associated with a significant increase in major adverse cardiac and cerebrovascular events (incidence rate ratio, 1.39, 95% confidence interval, 1.27-1.51) and nonsignificant increase in all-cause mortality (incidence rate ratio, 1.17, 95% confidence interval, 0.98-1.40). There was no significant statistical heterogeneity of treatment effect by SYNTAX score for major adverse cardiac and cerebrovascular events or mortality (P = .40 and P = .34, respectively). Results were consistent also for patients with left main and multivessel disease (major adverse cardiac and cerebrovascular events: P = .85 in left main, P = .78 in multivessel disease 0.78; mortality: P = .12 in left main; P = .34 in multivessel disease). Results of analysis based on ratios of incidence rate ratios were consistent with the main analysis. CONCLUSIONS: No significant association was found between SYNTAX score and the comparative effectiveness of percutaneous coronary intervention and coronary artery bypass grafting. These findings have implications for clinical practice, future guidelines, and the design of percutaneous coronary intervention versus coronary artery bypass grafting trials.
OBJECTIVES: The evidence supporting the use of the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) score for risk stratification is controversial. We performed a systematic review and meta-analysis of all the randomized controlled trials comparing percutaneous coronary intervention versus coronary artery bypass grafting that reported their outcomes stratified by SYNTAX score, focusing on between-strata comparisons. METHODS: A systematic review of MEDLINE, EMBASE, Cochrane Library databases was performed. Incidence rate ratios were pooled with a random effect model. Between-group statistical heterogeneity according to accepted SYNTAX score tertiles was computed in the main analysis. Ratios of incidence rate ratios were computed to appraise between-strata effect, as sensitivity analysis. Primary and secondary outcomes were major adverse cardiac and cerebrovascular events and all-cause mortality, respectively. Separate sub-analyses were performed for left main and multivessel disease. RESULTS: From 425 citations, 6 trials were eventually included (8269 patients [4134 percutaneous coronary interventions, 4135 coronary artery bypass graftings]; mean follow-up: 6.2 years [range: 3.8-10]). Overall, percutaneous coronary intervention was associated with a significant increase in major adverse cardiac and cerebrovascular events (incidence rate ratio, 1.39, 95% confidence interval, 1.27-1.51) and nonsignificant increase in all-cause mortality (incidence rate ratio, 1.17, 95% confidence interval, 0.98-1.40). There was no significant statistical heterogeneity of treatment effect by SYNTAX score for major adverse cardiac and cerebrovascular events or mortality (P = .40 and P = .34, respectively). Results were consistent also for patients with left main and multivessel disease (major adverse cardiac and cerebrovascular events: P = .85 in left main, P = .78 in multivessel disease 0.78; mortality: P = .12 in left main; P = .34 in multivessel disease). Results of analysis based on ratios of incidence rate ratios were consistent with the main analysis. CONCLUSIONS: No significant association was found between SYNTAX score and the comparative effectiveness of percutaneous coronary intervention and coronary artery bypass grafting. These findings have implications for clinical practice, future guidelines, and the design of percutaneous coronary intervention versus coronary artery bypass grafting trials.
Authors: Mario Gaudino; David Taggart; Hisayoshi Suma; John D Puskas; Filippo Crea; Massimo Massetti Journal: J Am Coll Cardiol Date: 2015-10-13 Impact factor: 24.094
Authors: Gilles Lemesle; Laurent Bonello; Axel de Labriolle; Daniel H Steinberg; Probal Roy; Tina L Pinto Slottow; Rebecca Torguson; Kimberly Kaneshige; Zhenyi Xue; William O Suddath; Lowell F Satler; Kenneth M Kent; Joseph Lindsay; Augusto D Pichard; Ron Waksman Journal: Catheter Cardiovasc Interv Date: 2009-04-01 Impact factor: 2.692
Authors: Timo Mäkikallio; Niels R Holm; Mitchell Lindsay; Mark S Spence; Andrejs Erglis; Ian B A Menown; Thor Trovik; Markku Eskola; Hannu Romppanen; Thomas Kellerth; Jan Ravkilde; Lisette O Jensen; Gintaras Kalinauskas; Rikard B A Linder; Markku Pentikainen; Anders Hervold; Adrian Banning; Azfar Zaman; Jamen Cotton; Erlend Eriksen; Sulev Margus; Henrik T Sørensen; Per H Nielsen; Matti Niemelä; Kari Kervinen; Jens F Lassen; Michael Maeng; Keith Oldroyd; Geoff Berg; Simon J Walsh; Colm G Hanratty; Indulis Kumsars; Peteris Stradins; Terje K Steigen; Ole Fröbert; Alastair N J Graham; Petter C Endresen; Matthias Corbascio; Olli Kajander; Uday Trivedi; Juha Hartikainen; Vesa Anttila; David Hildick-Smith; Leif Thuesen; Evald H Christiansen Journal: Lancet Date: 2016-10-31 Impact factor: 79.321
Authors: Amand F Schmidt; Maroeska M Rovers; Olaf H Klungel; Arno W Hoes; Mirjam J Knol; Mirjam Nielen; Antonius de Boer; Rolf H H Groenwold Journal: J Clin Epidemiol Date: 2013-03-16 Impact factor: 6.437
Authors: Daniel J F M Thuijs; A Pieter Kappetein; Patrick W Serruys; Friedrich-Wilhelm Mohr; Marie-Claude Morice; Michael J Mack; David R Holmes; Nick Curzen; Piroze Davierwala; Thilo Noack; Milan Milojevic; Keith D Dawkins; Bruno R da Costa; Peter Jüni; Stuart J Head Journal: Lancet Date: 2019-09-02 Impact factor: 79.321
Authors: Michael E Farkouh; Michael Domanski; George D Dangas; Lucas C Godoy; Michael J Mack; Flora S Siami; Taye H Hamza; Binita Shah; Giulio G Stefanini; Mandeep S Sidhu; Jean-François Tanguay; Krishnan Ramanathan; Samin K Sharma; John French; Whady Hueb; David J Cohen; Valentin Fuster Journal: J Am Coll Cardiol Date: 2018-11-11 Impact factor: 24.094
Authors: Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr Journal: N Engl J Med Date: 2009-02-18 Impact factor: 91.245
Authors: Michael E Farkouh; Michael Domanski; Lynn A Sleeper; Flora S Siami; George Dangas; Michael Mack; May Yang; David J Cohen; Yves Rosenberg; Scott D Solomon; Akshay S Desai; Bernard J Gersh; Elizabeth A Magnuson; Alexandra Lansky; Robin Boineau; Jesse Weinberger; Krishnan Ramanathan; J Eduardo Sousa; Jamie Rankin; Balram Bhargava; John Buse; Whady Hueb; Craig R Smith; Victoria Muratov; Sameer Bansilal; Spencer King; Michel Bertrand; Valentin Fuster Journal: N Engl J Med Date: 2012-11-04 Impact factor: 91.245